Publicacións (87) Publicacións de Pedro Jorge Marcos Rodríguez

2024

  1. Home Respiratory Therapies: SEPAR Technical Document for Institutional Decision Support

    Open Respiratory Archives, Vol. 6, Núm. 2

  2. Prognostic impact of chronic obstructive pulmonary disease and bronchial asthma in patients with heart failure

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 123-132

2023

  1. Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 59, Núm. 2, pp. 90-100

  2. Comprehensive analysis of clinical data for COVID-19 outcome estimation with machine learning models

    Biomedical Signal Processing and Control, Vol. 84

  3. Explainable learning to analyze the outcome of COVID-19 patients using clinical data

    Procedia Computer Science

  4. Proceso asistencial para el diagnóstico y tratamiento del paciente con déficit de alfa-1 antitripsina (DAAT)

    Conselleria de Sanidade

  5. Survival impact of previous statin therapy in patients hospitalized with COVID-19

    Medicina Clinica, Vol. 160, Núm. 1, pp. 1-9

2022

  1. Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection

    Archivos de Bronconeumologia, Vol. 58, Núm. 8, pp. 614-617

  2. Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis

    Archivos de Bronconeumologia, Vol. 58, Núm. 6, pp. 474-481

  3. Noninvasive Ventilation for Weaning and Extubation Respiratory Failure

    Noninvasive Mechanical Ventilation in Anesthesiology and Perioperative Medicine (Nova Science Publishers, Inc.), pp. 173-181

  4. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease

    PLoS ONE, Vol. 17, Núm. 2 February

  5. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease

    PloS one, Vol. 17, Núm. 2, pp. e0263140

2021

  1. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

    Chest, Vol. 159, Núm. 1, pp. 58-72

  2. COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation

    PLoS ONE, Vol. 16, Núm. 6 June

  3. Correction to: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study (European Journal of Clinical Microbiology & Infectious Diseases, (2020), 39, 8, (1513-1525), 10.1007/s10096-020-03870-3)

    European Journal of Clinical Microbiology and Infectious Diseases

  4. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285

  5. GesEPOC 2021 and GOLD 2021. Perfect is the enemy of good

    Open Respiratory Archives, Vol. 3, Núm. 4

  6. Knowledge of Chronic Obstructive Pulmonary Disease (COPD) in the Galician Population: “CoñecEPOC” Study

    Open Respiratory Archives, Vol. 3, Núm. 3

  7. One year of the covid-19 pandemic in galicia: A global view of age-group statistics during three waves

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 10

  8. Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational Study

    Archivos de Bronconeumologia, Vol. 57, Núm. 11, pp. 690-696